The Clorox Company $CLX Shares Bought by Assetmark Inc.

Assetmark Inc. grew its position in The Clorox Company (NYSE:CLX) by 566.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,388 shares of the company’s stock after buying an additional 2,880 shares during the quarter. Assetmark Inc.’s holdings in Clorox were worth $407,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Simplicity Wealth LLC boosted its holdings in shares of Clorox by 157.3% during the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,198 shares during the last quarter. Raymond James Financial Inc. lifted its position in Clorox by 15.6% during the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after buying an additional 36,352 shares during the period. OneDigital Investment Advisors LLC acquired a new stake in Clorox in the 1st quarter worth about $247,000. AlphaQuest LLC grew its holdings in Clorox by 109.4% in the 1st quarter. AlphaQuest LLC now owns 11,873 shares of the company’s stock valued at $1,748,000 after buying an additional 6,203 shares during the period. Finally, Nordea Investment Management AB increased its stake in shares of Clorox by 16.3% during the 2nd quarter. Nordea Investment Management AB now owns 484,352 shares of the company’s stock valued at $57,827,000 after acquiring an additional 68,026 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.63% of the stock is owned by corporate insiders.

Clorox Stock Up 1.0%

NYSE CLX opened at $107.37 on Friday. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a fifty-two week low of $106.14 and a fifty-two week high of $171.37. The business has a 50 day moving average price of $119.49 and a two-hundred day moving average price of $124.94. The stock has a market cap of $13.07 billion, a PE ratio of 16.47, a P/E/G ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business’s quarterly revenue was down 18.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd were given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend was Wednesday, October 22nd. Clorox’s dividend payout ratio is presently 77.86%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research analyst reports. BNP Paribas Exane decreased their target price on shares of Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a research report on Friday, October 17th. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 28th. TD Cowen lowered their price objective on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday, October 1st. Jefferies Financial Group restated a “buy” rating and set a $152.00 price objective on shares of Clorox in a report on Tuesday. Finally, Citigroup reduced their target price on Clorox from $130.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Reduce” and an average price target of $127.60.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.